Bilirubin neurotoxicity is associated with proteasome inhibition

Hongbiao Huang, Mingxing Guo, Ningning Liu, Chong Zhao, Haoyu Chen, Xiaoli Wang, Siyan Liao, Ping Zhou, Yuning Liao, Xin Chen, Xiaoying Lan, Jinghong Chen, Dacai Xu, Xiaofen Li, Xianping Shi, Li Yu, Yuqiang Nie, Xuejun Wang, Chang E. Zhang, Jinbao Liu

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The molecular mechanism underlying bilirubin neurotoxicity remains obscure. Ubiquitin-proteasome system-mediated proteolysis is pivotal to virtually all cellular processes and cell survival. Here we report for the first time that bilirubin at a clinically relevant elevated level impairs proteasomal function via inhibiting both the 19S proteasome-associated deubiquitinases (USP14 and UCHL5) and the chymotrypsin-like (CT-like) peptidase activity of 20S proteasomes, thereby contributing to bilirubin neurotoxicity. This is supported by multiple lines of evidence. First, sera from patients with hyperbilirubinemia were able to inhibit the peptidase activity of purified 20S proteasome in vitro in a bilirubin concentration-dependent manner; meanwhile, the blood cells of these patients showed significantly increased levels of ubiquitinated proteins (Ub-prs), consistent with proteasome inhibition. Second, intracerebroventricular injection to adult rats or intraperitoneal injections to neonatal rats of bilirubin-induced neural accumulation of Ub-prs, concurrent with other neural pathology; and brain malfunction and pathology induced by neonatal exposure to hyperbilirubinemia were detectable in the rats during their adulthood. Third, in primary cultures of hippocampal neurons, bilirubin strikingly induced Ub-pr accumulation before the activation of cell death pathway becomes discernible. Finally, bilirubin in vitro directly inhibited both the deubiquitination activity of proteasome-associated USP14 and UCHL5 and the CT-like peptidase activity of purified 20S proteasomes, in a dose-dependent manner. Hence, this study has discovered that increased bilirubin at a clinically achievable level can act as a proteasome inhibitor via targeting the 19S proteasome-associated deubiquitinases (DUBs) and, perhaps to a less extent, the 20S proteasome, identifying a novel mechanism for bilirubin neurotoxicity.

Original languageEnglish (US)
Article numbere2877
JournalCell Death and Disease
Volume8
Issue number6
DOIs
StatePublished - Jun 15 2017

Fingerprint

Proteasome Endopeptidase Complex
Bilirubin
Ubiquitinated Proteins
Peptide Hydrolases
Hyperbilirubinemia
Chymotrypsin
Pathology
Proteasome Inhibitors
Ubiquitin
Intraperitoneal Injections
Proteolysis
Blood Cells
Cell Survival
Cell Death
Neurons
Injections
Brain
Serum

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Cite this

Huang, H., Guo, M., Liu, N., Zhao, C., Chen, H., Wang, X., ... Liu, J. (2017). Bilirubin neurotoxicity is associated with proteasome inhibition. Cell Death and Disease, 8(6), [e2877]. https://doi.org/10.1038/cddis.2017.274

Bilirubin neurotoxicity is associated with proteasome inhibition. / Huang, Hongbiao; Guo, Mingxing; Liu, Ningning; Zhao, Chong; Chen, Haoyu; Wang, Xiaoli; Liao, Siyan; Zhou, Ping; Liao, Yuning; Chen, Xin; Lan, Xiaoying; Chen, Jinghong; Xu, Dacai; Li, Xiaofen; Shi, Xianping; Yu, Li; Nie, Yuqiang; Wang, Xuejun; Zhang, Chang E.; Liu, Jinbao.

In: Cell Death and Disease, Vol. 8, No. 6, e2877, 15.06.2017.

Research output: Contribution to journalArticle

Huang, H, Guo, M, Liu, N, Zhao, C, Chen, H, Wang, X, Liao, S, Zhou, P, Liao, Y, Chen, X, Lan, X, Chen, J, Xu, D, Li, X, Shi, X, Yu, L, Nie, Y, Wang, X, Zhang, CE & Liu, J 2017, 'Bilirubin neurotoxicity is associated with proteasome inhibition', Cell Death and Disease, vol. 8, no. 6, e2877. https://doi.org/10.1038/cddis.2017.274
Huang, Hongbiao ; Guo, Mingxing ; Liu, Ningning ; Zhao, Chong ; Chen, Haoyu ; Wang, Xiaoli ; Liao, Siyan ; Zhou, Ping ; Liao, Yuning ; Chen, Xin ; Lan, Xiaoying ; Chen, Jinghong ; Xu, Dacai ; Li, Xiaofen ; Shi, Xianping ; Yu, Li ; Nie, Yuqiang ; Wang, Xuejun ; Zhang, Chang E. ; Liu, Jinbao. / Bilirubin neurotoxicity is associated with proteasome inhibition. In: Cell Death and Disease. 2017 ; Vol. 8, No. 6.
@article{0a4807187c1345b5949f1244bea878ce,
title = "Bilirubin neurotoxicity is associated with proteasome inhibition",
abstract = "The molecular mechanism underlying bilirubin neurotoxicity remains obscure. Ubiquitin-proteasome system-mediated proteolysis is pivotal to virtually all cellular processes and cell survival. Here we report for the first time that bilirubin at a clinically relevant elevated level impairs proteasomal function via inhibiting both the 19S proteasome-associated deubiquitinases (USP14 and UCHL5) and the chymotrypsin-like (CT-like) peptidase activity of 20S proteasomes, thereby contributing to bilirubin neurotoxicity. This is supported by multiple lines of evidence. First, sera from patients with hyperbilirubinemia were able to inhibit the peptidase activity of purified 20S proteasome in vitro in a bilirubin concentration-dependent manner; meanwhile, the blood cells of these patients showed significantly increased levels of ubiquitinated proteins (Ub-prs), consistent with proteasome inhibition. Second, intracerebroventricular injection to adult rats or intraperitoneal injections to neonatal rats of bilirubin-induced neural accumulation of Ub-prs, concurrent with other neural pathology; and brain malfunction and pathology induced by neonatal exposure to hyperbilirubinemia were detectable in the rats during their adulthood. Third, in primary cultures of hippocampal neurons, bilirubin strikingly induced Ub-pr accumulation before the activation of cell death pathway becomes discernible. Finally, bilirubin in vitro directly inhibited both the deubiquitination activity of proteasome-associated USP14 and UCHL5 and the CT-like peptidase activity of purified 20S proteasomes, in a dose-dependent manner. Hence, this study has discovered that increased bilirubin at a clinically achievable level can act as a proteasome inhibitor via targeting the 19S proteasome-associated deubiquitinases (DUBs) and, perhaps to a less extent, the 20S proteasome, identifying a novel mechanism for bilirubin neurotoxicity.",
author = "Hongbiao Huang and Mingxing Guo and Ningning Liu and Chong Zhao and Haoyu Chen and Xiaoli Wang and Siyan Liao and Ping Zhou and Yuning Liao and Xin Chen and Xiaoying Lan and Jinghong Chen and Dacai Xu and Xiaofen Li and Xianping Shi and Li Yu and Yuqiang Nie and Xuejun Wang and Zhang, {Chang E.} and Jinbao Liu",
year = "2017",
month = "6",
day = "15",
doi = "10.1038/cddis.2017.274",
language = "English (US)",
volume = "8",
journal = "Cell Death and Disease",
issn = "2041-4889",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Bilirubin neurotoxicity is associated with proteasome inhibition

AU - Huang, Hongbiao

AU - Guo, Mingxing

AU - Liu, Ningning

AU - Zhao, Chong

AU - Chen, Haoyu

AU - Wang, Xiaoli

AU - Liao, Siyan

AU - Zhou, Ping

AU - Liao, Yuning

AU - Chen, Xin

AU - Lan, Xiaoying

AU - Chen, Jinghong

AU - Xu, Dacai

AU - Li, Xiaofen

AU - Shi, Xianping

AU - Yu, Li

AU - Nie, Yuqiang

AU - Wang, Xuejun

AU - Zhang, Chang E.

AU - Liu, Jinbao

PY - 2017/6/15

Y1 - 2017/6/15

N2 - The molecular mechanism underlying bilirubin neurotoxicity remains obscure. Ubiquitin-proteasome system-mediated proteolysis is pivotal to virtually all cellular processes and cell survival. Here we report for the first time that bilirubin at a clinically relevant elevated level impairs proteasomal function via inhibiting both the 19S proteasome-associated deubiquitinases (USP14 and UCHL5) and the chymotrypsin-like (CT-like) peptidase activity of 20S proteasomes, thereby contributing to bilirubin neurotoxicity. This is supported by multiple lines of evidence. First, sera from patients with hyperbilirubinemia were able to inhibit the peptidase activity of purified 20S proteasome in vitro in a bilirubin concentration-dependent manner; meanwhile, the blood cells of these patients showed significantly increased levels of ubiquitinated proteins (Ub-prs), consistent with proteasome inhibition. Second, intracerebroventricular injection to adult rats or intraperitoneal injections to neonatal rats of bilirubin-induced neural accumulation of Ub-prs, concurrent with other neural pathology; and brain malfunction and pathology induced by neonatal exposure to hyperbilirubinemia were detectable in the rats during their adulthood. Third, in primary cultures of hippocampal neurons, bilirubin strikingly induced Ub-pr accumulation before the activation of cell death pathway becomes discernible. Finally, bilirubin in vitro directly inhibited both the deubiquitination activity of proteasome-associated USP14 and UCHL5 and the CT-like peptidase activity of purified 20S proteasomes, in a dose-dependent manner. Hence, this study has discovered that increased bilirubin at a clinically achievable level can act as a proteasome inhibitor via targeting the 19S proteasome-associated deubiquitinases (DUBs) and, perhaps to a less extent, the 20S proteasome, identifying a novel mechanism for bilirubin neurotoxicity.

AB - The molecular mechanism underlying bilirubin neurotoxicity remains obscure. Ubiquitin-proteasome system-mediated proteolysis is pivotal to virtually all cellular processes and cell survival. Here we report for the first time that bilirubin at a clinically relevant elevated level impairs proteasomal function via inhibiting both the 19S proteasome-associated deubiquitinases (USP14 and UCHL5) and the chymotrypsin-like (CT-like) peptidase activity of 20S proteasomes, thereby contributing to bilirubin neurotoxicity. This is supported by multiple lines of evidence. First, sera from patients with hyperbilirubinemia were able to inhibit the peptidase activity of purified 20S proteasome in vitro in a bilirubin concentration-dependent manner; meanwhile, the blood cells of these patients showed significantly increased levels of ubiquitinated proteins (Ub-prs), consistent with proteasome inhibition. Second, intracerebroventricular injection to adult rats or intraperitoneal injections to neonatal rats of bilirubin-induced neural accumulation of Ub-prs, concurrent with other neural pathology; and brain malfunction and pathology induced by neonatal exposure to hyperbilirubinemia were detectable in the rats during their adulthood. Third, in primary cultures of hippocampal neurons, bilirubin strikingly induced Ub-pr accumulation before the activation of cell death pathway becomes discernible. Finally, bilirubin in vitro directly inhibited both the deubiquitination activity of proteasome-associated USP14 and UCHL5 and the CT-like peptidase activity of purified 20S proteasomes, in a dose-dependent manner. Hence, this study has discovered that increased bilirubin at a clinically achievable level can act as a proteasome inhibitor via targeting the 19S proteasome-associated deubiquitinases (DUBs) and, perhaps to a less extent, the 20S proteasome, identifying a novel mechanism for bilirubin neurotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=85020910210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020910210&partnerID=8YFLogxK

U2 - 10.1038/cddis.2017.274

DO - 10.1038/cddis.2017.274

M3 - Article

C2 - 28617443

AN - SCOPUS:85020910210

VL - 8

JO - Cell Death and Disease

JF - Cell Death and Disease

SN - 2041-4889

IS - 6

M1 - e2877

ER -